This Article Full Text Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Terrasson, J. Articles by Davrinche, C. Search for Related Content PubMed PubMed Citation Articles by Terrasson, J. Articles by Davrinche, C.

p73-Dependent Apoptosis through Death Receptor: Impairment by Human Cytomegalovirus Infection

¹ Institut National de la Sante et de la Recherche Medicale U563, CHU Purpan, Toulouse, France; ² Centre National de la Recherche Scientifique, Institut Gustave Roussy, Villejuif, France; and ³ Molecular and Functional Genomics Department, Sanofi-Synthélabo Recherche, Labège, France

Requests for reprints: Christian Davrinche, Institut National de la Sante et de la Recherche Medicale U563,UPS, IFR 30, BP3028, 31024 Toulouse Cédex 3, France. Phone: 33-5-6274-8385; Fax: 33-5-6274-4558; E-mail: davrinch{at}toulouse.inserm.fr.

The discovery of p73, a p53-related protein with various isotypes resulting from different promoter usage or splicing events, provided new insights into regulation of neurogenesis and tumorigenesis. Among p73 isoforms described thus far, TA-truncated molecules (N) appeared as key proteins according to their antagonistic activity against transcription factor activity of p53 family members. We previously showed that infection by human cytomegalovirus (HCMV) induced drug resistance and altered p53- and p73-dependent apoptosis of infected cells through accumulation of N-p73. In accordance with the ability of p53 to induce apoptosis through death receptors, we asked whether p73 activation could compensate for p53 deficiency. We showed that p73 transcriptional activity sensitized cells to apoptosis through death receptors in a caspase-dependent pathway. Expression of the death-inducing signaling complex (DISC) proteins was unchanged, whereas p73 activation through either cisplatin treatment or ectopic overexpression induced up-regulation of Fas transcription and expression at cell surface. According to its ability to flood cells with N-p73, HCMV inhibited p73-dependent Fas-mediated apoptosis, gaining an additional trick to favor its survival in the host cell. Owing to the involvement of p53- and p73-dependent death receptor signaling in development of the central nervous system, immune surveillance of neural cells, and sensitivity of tumors to drugs, our previous and present data prompt us to consider stabilization of N-p73 by HCMV as a possible mechanism in impairment of embryogenesis and in tumorigenesis.

Key Words: p73 • death receptors • apoptosis • HCMV

This article has been cited by other articles:

				Y. Ma, W.-D. Yu, P. A. Hershberger, G. Flynn, R.-X. Kong, D. L. Trump, and C. S. Johnson 1{alpha},25-Dihydroxyvitamin D3 potentiates cisplatin antitumor activity by p73 induction in a squamous cell carcinoma model Mol. Cancer Ther., September 1, 2008; 7(9): 3047 - 3055. [Abstract] [Full Text] [PDF]

				C. S. Cobbs, L. Soroceanu, S. Denham, W. Zhang, and M. H. Kraus Modulation of Oncogenic Phenotype in Human Glioma Cells by Cytomegalovirus IE1-Mediated Mitogenicity Cancer Res., February 1, 2008; 68(3): 724 - 730. [Abstract] [Full Text] [PDF]